Cancer Immunotherapy Breakthrough: CTLA-4 Inhibitors Transforming...

agregó una foto Health

2025-09-23 09:44:23

Cancer Immunotherapy Breakthrough: CTLA-4 Inhibitors Transforming Treatment

Understanding CTLA-4 and Its Role in Oncology Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is an essential checkpoint receptor on T-cells that normally prevents overactivation of the immune response. Cancer cells exploit this pathway to escape immune detection and continue multiplying. By blocking CTLA-4, inhibitors empower T-cells to recognize and eliminate tumor cells more...

0 Commentarios 0 Acciones 650 Views 0 Vista previa